2021International Trade and Trade PolicyOpen access

CURRENT TRENDS IN INTERNATIONAL MERGERS AND ACQUISITIONS OF PHARMACEUTICAL COMPANIES

Yana Sergeevna Sinitsova

Open full text 1 citations

Abstract

The article analyzes the results of mergers and acquisitions of global pharmaceutical companies and their impact on the global pharmaceutical industry. The relevance of this research is determined by the high significance of mergers and acquisitions of global pharmaceutical companies on the global pharmaceutical industry and market. A comprehensive approach is used to assess the impact of mergers and acquisitions of pharmaceutical companies on the global pharmaceutical industry. The article presents statistical data on the volume and number of venture investments in the pharmaceutical and biotechnological industries. The reasons for mergers and acquisitions by pharmaceutical companies, as well as the dynamics of the activity of such transactions, are determined. The geographical structure of stock transactions and the total number of mergers and acquisitions of pharmaceutical companies are presented, as well as examples of the largest mergers and acquisitions of pharmaceutical companies.

Open-access reader

About this research paper

What this paper is about

The article analyzes the results of mergers and acquisitions of global pharmaceutical companies and their impact on the global pharmaceutical industry. The relevance of this research is determined by the high significance of mergers and acquisitions of global pharmaceutical companies on the global pharmaceutical industry and market. A comprehensive approach is used to assess the impact of mergers and acquisitions of pharmaceutical companies on the global pharmaceutical industry. The article presents statistical data on the volume and number of venture investments in the pharmaceutical and biotechnological industries. The reasons for mergers and acquisitions by pharmaceutical companies, as well as the dynamics of the activity of such transactions, are determined. The geographical structure of stock transactions and the total number of mergers and acquisitions of pharmaceutical companies are presented, as well as examples of the largest mergers and acquisitions of pharmaceutical companies.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The article analyzes the results of mergers and acquisitions of global pharmaceutical companies and their impact on the global pharmaceutical industry. The relevance of this research is determined by the high significance of mergers and acquisitions of global pharmaceutical companies on the global pharmaceutical industry and market. A comprehensive approach is used to assess the impact of mergers and acquisitions of pharmaceutical companies on the global pharmaceutical industry. The article presents statistical data on the volume and number of venture investments in the pharmaceutical and biotechnological industries. The reasons for mergers and acquisitions by pharmaceutical companies, as well as the dynamics of the activity of such transactions, are determined. The geographical structure of stock transactions and the total number of mergers and acquisitions of pharmaceutical companies are presented, as well as examples of the largest mergers and acquisitions of pharmaceutical companies.

Key concepts: Mergers and acquisitions, Pharmaceutical industry, Business, Stock (firearms), Relevance (law), Industrial organization, Commerce, Finance

Related papers

Back to paper searchBrowse research topicsOriginal source
CURRENT TRENDS IN INTERNATIONAL MERGERS AND ACQUISITIONS OF PHARMACEUTICAL COMPANIES — Research Paper | ScholarLens